Osteoporosis study: Protelos have significant bone-forming activity than bisphosphona
Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.
More... |
Re: Osteoporosis study: Protelos have significant bone-forming activity than bisphosp
I take Strontium since I bagged the Clondonate. Easier on my gizzard, and frankly, I just have a nagging doubt about bisphosphonates.
|
All times are GMT -7. The time now is 01:12 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021